Defining standards of CARE for invasive fungal diseases in the ICU

J Antimicrob Chemother. 2019 Mar 1;74(Suppl 2):ii9-ii15. doi: 10.1093/jac/dkz038.

Abstract

The aim of this article is to review the current recommendations for the diagnosis and treatment of invasive fungal infection in the ICU setting and to explore whether there are standards of care for this patient population. The text focuses mainly on the two most common invasive fungal diseases that afflict non-neutropenic patients: candidaemia and invasive candidosis (IC), and invasive pulmonary aspergillosis (IPA).

Publication types

  • Review

MeSH terms

  • Antifungal Agents / therapeutic use*
  • Aspergillus / genetics
  • Candida / genetics
  • Candidiasis, Invasive / diagnosis
  • Candidiasis, Invasive / drug therapy
  • Congresses as Topic
  • Humans
  • Intensive Care Units / standards*
  • Invasive Fungal Infections / diagnosis*
  • Invasive Fungal Infections / drug therapy*
  • Invasive Pulmonary Aspergillosis / diagnosis
  • Invasive Pulmonary Aspergillosis / drug therapy
  • Practice Guidelines as Topic
  • Standard of Care*

Substances

  • Antifungal Agents